Access
This article is part of Nature's premium content.
Published online 21 November 2007 | Nature 450, 471 (2007) | doi:10.1038/450471a
News: Business
Trip into the unknown
A plant in Uganda hopes to sell cut-price drugs by taking advantage of exemptions from rules that protect patents. But its operators face major obstacles, as Tatum Anderson reports.
On the outskirts of Kampala, and rather at odds with the dusty, low-rise buildings around it, stands a state-of-the-art, glass-fronted pharmaceutical plant.
Opened with great fanfare last month by Yoweri Museveni, the president of Uganda, the factory will manufacture drugs to treat HIV/AIDS and malaria for markedly less than the cost of imported drugs.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
